VolitionRX Ltd (NYSE American:VNRX)
| 1.52 Delayed Data As of Jun 05 |  -0.02 / -1.30%Today’s Change | 1.31 Today|||52-Week Range 2.74 | -37.45% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | -9.5M | -11.9M | -14.8M | -18.0M | |
| Depreciation | 236.3K | 309.4K | 528.2K | 636.4K | ||
| Total Other Cash Flow | 964.6K | 1.5M | 2.5M | 2.6M | ||
| Funds From Operations | -8.3M | -10.1M | -11.7M | -14.8M | ||
| Funds From/For Other Operating Expenses | 437.1K | -1.1M | 480.7K | -45.9K | ||
| Net Cash Flow - Operating Activities | -8.8M | -9.1M | -12.2M | -14.7M | ||
| Investing | Capital Expenditures | -297.2K | -415.1K | -1.4M | -301.8K | |
| Net Cash Flow Investing | -352.2K | -415.1K | -1.4M | -301.8K | ||
| Financing | Short Term Borrowings | 0.00 | -- | -- | -- | -- |
| Long Term Borrowings | 223.2K | 474.8K | 1.2M | 1.2M | ||
| Long Term Debt Reduction | 0.00 | -552.5K | -188.0K | -574.3K | ||
| Net Proceeds Stock Sale | 12.5M | 25.3M | 998.4K | 17.2M | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 195.0K | 361.3K | 0.00 | 177.1K | ||
| Other Uses - Financing | 33.2K | 206.5K | 45.4K | 40.9K | ||
| Net Cash Flow - Financing | 12.9M | 25.4M | 2.0M | 18.0M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | 13.0K | -145.8K | 89.0K | 378.7K | |
| Net Change In Cash | 3.8M | 15.9M | -11.7M | 2.9M | ||
